Treatment of Overactive Bladder With Anticholinergic Agents
- Conditions
- Overactive Bladder
- Interventions
- Registration Number
- NCT07046156
- Lead Sponsor
- Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital
- Brief Summary
This study aims to evaluate the efficacy and adverse effect incidence of three different anticholinergics (oxybutinin, propiverine, and tolterodine) that are used in children with overactive bladder.
- Detailed Description
A total of approximately 150 patients with overactive bladder will be evaluated retrospectively. Clinical and demographic data and voiding diaries of these patients will be evaluated. For this purpose, patients will be divided into mainly three groups according to the anticholinergic agent used.
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 120
- Patients diagnosed with overactive bladder
- Patients treated with an anticholinergic
- Presence of anatomical or neurological problems
- Patients with missing data
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Oxybutynin Oxybutynin Cl Patients treated with oxybutynin Propiverine propiverine Patients treated with propiverine Tolterodine Tolterodine Patients treated with tolterodine
- Primary Outcome Measures
Name Time Method Number of patients treated with anticholinergic 6 months Number of patients with drug related adverse effects 1 month
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Sancaktepe Sehit Prof dr Ilhan Varank Training and Research Hospital
🇹🇷Istanbul, Turkey
Sancaktepe Sehit Prof dr Ilhan Varank Training and Research Hospital🇹🇷Istanbul, Turkey